Sacramento area med-tech company faces stock delisting

Cesca Therapeutics Inc., a Rancho Cordova medical device company, said Friday it is facing possible delisting by Nasdaq because of its low stock price.

Cesca, which makes a variety of diagnostic and medical devices, said it received the notice because it stock price has closed below $1 a share for 30 straight business days.

The company said it has until Sept. 28 to get back into compliance or face delisting. Compliance means the stock must close above $1 for at least 10 straight business days.

If delisted, the company could seek to be traded on a less prominent exchange.

Cesca has faced this problem before. It was threatened with possible delisting in 2009, when it was known as Thermogenesis.

This story was originally published April 3, 2015 at 3:59 PM with the headline "Sacramento area med-tech company faces stock delisting."